ROS Scavenging Nanozyme Modulates Immunosuppression for Sensitized Cancer Immunotherapy
Wenjing Mo(Nanjing University of Chinese Medicine), Hongqian Guo(Nanjing Drum Tower Hospital), Shujie Liu(Shanxi University), Xinan Sheng(Peking University), Xiaozhi Zhao(Brigham and Women's Hospital), Sheng Yao(BioReliance (United States)), Fayun Wei(Nanjing Drum Tower Hospital), Yuhang Li(Nanjing University of Chinese Medicine), Wenlong Zhang(Jilin University), Meng Ding(Chinese Academy of Sciences), Wenmin Cao(Nanjing University), Longxiyu Meng(Nanjing Drum Tower Hospital), Wenli Diao(Nanjing University), Hui Wei(Qilu Hospital of Shandong University)
Cited by 48
Related Papers
Nanozyme: An emerging alternative to natural enzyme for biosensing and immunoassay
|TrAC Trends in Analytical Chemistry|2018|725
ROS scavenging Mn<sub>3</sub>O<sub>4</sub>nanozymes for<i>in vivo</i>anti-inflammation
|Chemical Science|2018|617
Nanozymes: A clear definition with fuzzy edges
|Nano Today|2021|559
Safety, efficacy and tumor mutational burden as a biomarker of overall survival benefit in chemo-refractory gastric cancer treated with toripalimab, a PD-1 antibody in phase Ib/II clinical trial NCT02915432
|Annals of Oncology|2019|475
Simple and sensitive aptamer-based colorimetric sensing of protein using unmodified gold nanoparticle probes
|Chemical Communications|2007|474